These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 11840380

  • 1. Cigarette smoking predicts faster progression of type 2 established diabetic nephropathy despite ACE inhibition.
    Chuahirun T, Wesson DE.
    Am J Kidney Dis; 2002 Feb; 39(2):376-82. PubMed ID: 11840380
    [Abstract] [Full Text] [Related]

  • 2. Cigarette smoking and increased urine albumin excretion are interrelated predictors of nephropathy progression in type 2 diabetes.
    Chuahirun T, Khanna A, Kimball K, Wesson DE.
    Am J Kidney Dis; 2003 Jan; 41(1):13-21. PubMed ID: 12500217
    [Abstract] [Full Text] [Related]

  • 3. Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist.
    Martínez-Ramírez HR, Jalomo-Martínez B, Cortés-Sanabria L, Rojas-Campos E, Barragán G, Alfaro G, Cueto-Manzano AM.
    Am J Kidney Dis; 2006 Jan; 47(1):78-87. PubMed ID: 16377388
    [Abstract] [Full Text] [Related]

  • 4. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H, Kanno Y, Nakamoto H, Okada H, Sugahara S.
    Clin Exp Hypertens; 2005 Jan; 27(2-3):129-38. PubMed ID: 15835375
    [Abstract] [Full Text] [Related]

  • 5. Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for diabetic nephropathy: a retrospective comparison.
    Robles NR, Romero B, Fernandez-Carbonero E, Sánchez-Casado E, Cubero JJ.
    J Renin Angiotensin Aldosterone Syst; 2009 Dec; 10(4):195-200. PubMed ID: 20026868
    [Abstract] [Full Text] [Related]

  • 6. Cigarette smoking exacerbates and its cessation ameliorates renal injury in type 2 diabetes.
    Chuahirun T, Simoni J, Hudson C, Seipel T, Khanna A, Harrist RB, Wesson DE.
    Am J Med Sci; 2004 Feb; 327(2):57-67. PubMed ID: 14770020
    [Abstract] [Full Text] [Related]

  • 7. Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy.
    Salako BL, Finomo FO, Kadiri S, Arije A, Olatosin AO.
    Afr J Med Med Sci; 2002 Mar; 31(1):53-7. PubMed ID: 12518931
    [Abstract] [Full Text] [Related]

  • 8. Influence of cigarette-smoking on the progression of clinical diabetic nephropathy in type 2 diabetic patients.
    Biesenbach G, Grafinger P, Janko O, Zazgornik J.
    Clin Nephrol; 1997 Sep; 48(3):146-50. PubMed ID: 9342485
    [Abstract] [Full Text] [Related]

  • 9. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM, Mauer M, International Diabetic Nephropathy Study Group.
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [Abstract] [Full Text] [Related]

  • 10. Effects of smoking on renal function in patients with type 1 and type 2 diabetes mellitus.
    Orth SR, Schroeder T, Ritz E, Ferrari P.
    Nephrol Dial Transplant; 2005 Nov; 20(11):2414-9. PubMed ID: 16046507
    [Abstract] [Full Text] [Related]

  • 11. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.
    Ravid M, Lang R, Rachmani R, Lishner M.
    Arch Intern Med; 1996 Feb 12; 156(3):286-9. PubMed ID: 8572838
    [Abstract] [Full Text] [Related]

  • 12. Spironolactone in type 2 diabetic nephropathy: Effects on proteinuria, blood pressure and renal function.
    van den Meiracker AH, Baggen RG, Pauli S, Lindemans A, Vulto AG, Poldermans D, Boomsma F.
    J Hypertens; 2006 Nov 12; 24(11):2285-92. PubMed ID: 17053552
    [Abstract] [Full Text] [Related]

  • 13. Are angiotensin converting enzyme inhibitors superior to beta blockers in retarding progressive renal function decline?
    van Essen GG, Apperloo AJ, Rensma PL, Stegeman CA, Sluiter WJ, de Zeeuw D, de Jong PE.
    Kidney Int Suppl; 1997 Dec 12; 63():S58-62. PubMed ID: 9407423
    [Abstract] [Full Text] [Related]

  • 14. ACE-inhibition and renoprotection in early diabetic nephropathy. Response to enalapril acutely and in long-term combination with conventional antihypertensive treatment.
    Pedersen MM, Christensen CK, Hansen KW, Christiansen JS, Mogensen CE.
    Clin Invest Med; 1991 Dec 12; 14(6):642-51. PubMed ID: 1665407
    [Abstract] [Full Text] [Related]

  • 15. Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study.
    Bakris GL, Weir MR, Shanifar S, Zhang Z, Douglas J, van Dijk DJ, Brenner BM, RENAAL Study Group.
    Arch Intern Med; 2003 Jul 14; 163(13):1555-65. PubMed ID: 12860578
    [Abstract] [Full Text] [Related]

  • 16. Deletion insertion polymorphism of the angiotensin converting enzyme gene and progression of diabetic nephropathy.
    Björck S, Blohmé G, Sylvén C, Mulec H.
    Nephrol Dial Transplant; 1997 Jul 14; 12 Suppl 2():67-70. PubMed ID: 9269704
    [Abstract] [Full Text] [Related]

  • 17. Renal protection and angiotensin converting enzyme inhibition in microalbuminuric type I and type II diabetic patients.
    Cooper ME.
    J Hypertens Suppl; 1996 Dec 14; 14(6):S11-4. PubMed ID: 9023709
    [Abstract] [Full Text] [Related]

  • 18. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L, Kocks MJ, Laverman GD, Navis G.
    Minerva Med; 2004 Oct 14; 95(5):395-409. PubMed ID: 15467515
    [Abstract] [Full Text] [Related]

  • 19. Continued smoking exacerbates but cessation ameliorates progression of early type 2 diabetic nephropathy.
    Phisitkul K, Hegazy K, Chuahirun T, Hudson C, Simoni J, Rajab H, Wesson DE.
    Am J Med Sci; 2008 Apr 14; 335(4):284-91. PubMed ID: 18414067
    [Abstract] [Full Text] [Related]

  • 20. [Clinical and biochemical aspects of diabetic nephropathy].
    Artenie A, Artenie R, Covic M, Haulică I.
    Rev Med Chir Soc Med Nat Iasi; 2001 Apr 14; 105(3):462-8. PubMed ID: 12092174
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.